Structures by: Van Meervelt L. U.
Total: 256
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-samarium(iii)
C6H10F18N3O17S6Sm
CrystEngComm (2015) 17, 37 7142
a=12.9489(3)Å b=18.4605(5)Å c=12.9858(3)Å
α=90.00° β=94.507(2)° γ=90.00°
Triaqua-tris(bis(trifluoromethylsulfonyl)imide-O,O')-cerium(iii)
C6H6Ce1F18N3O15S6
CrystEngComm (2015) 17, 37 7142
a=18.51715(13)Å b=18.51715(13)Å c=18.51715(13)Å
α=90.00° β=90.00° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-dysprosium(iii)
C6H10DyF18N3O17S6
CrystEngComm (2015) 17, 37 7142
a=12.8735(6)Å b=18.3588(9)Å c=12.9082(6)Å
α=90.00° β=94.119(4)° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-terbium(iii)
C6H10F18N3O17S6Tb
CrystEngComm (2015) 17, 37 7142
a=12.9085(3)Å b=18.3690(4)Å c=12.9307(3)Å
α=90.00° β=94.275(2)° γ=90.00°
Pentaaqua-tris(bis(trifluoromethylsulfonyl)imide-O)-erbium(iii)
C6H10ErF18N3O17S6
CrystEngComm (2015) 17, 37 7142
a=12.8788(4)Å b=18.2797(7)Å c=12.8814(5)Å
α=90.00° β=94.524(3)° γ=90.00°
C24H26N4O3
C24H26N4O3
Green Chem. (2015) 17, 6 3314
a=6.6676(7)Å b=7.3731(7)Å c=21.962(3)Å
α=98.895(9)° β=91.912(9)° γ=99.057(8)°
C12H36CoO6S6,2(C2F6NO4S2)
C12H36CoO6S6,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 14 4975-4986
a=8.3379(5)Å b=11.6098(6)Å c=12.2297(6)Å
α=111.206(5)° β=98.414(5)° γ=100.431(5)°
C6H24CoN6,2(C2F6NO4S2)
C6H24CoN6,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 14 4975-4986
a=11.2674(6)Å b=12.6042(5)Å c=19.7795(8)Å
α=90° β=90° γ=90°
C30H30CoN6O6,2(C2F6NO4S2)
C30H30CoN6O6,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 14 4975-4986
a=12.8271(5)Å b=8.3492(3)Å c=22.0771(8)Å
α=90° β=99.636(3)° γ=90°
2(C12H27Co0.5N3O3),2(C2F6NO4S2)
2(C12H27Co0.5N3O3),2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 14 4975-4986
a=22.1541(10)Å b=10.2909(3)Å c=23.8460(10)Å
α=90° β=116.196(6)° γ=90°
C36H24CoN6,2(C2F6NO4S2),0.5(C7H8),0.25(C7H7)
C36H24CoN6,2(C2F6NO4S2),0.5(C7H8),0.25(C7H7)
Dalton transactions (Cambridge, England : 2003) (2018) 47, 14 4975-4986
a=18.3290(2)Å b=23.1050(3)Å c=23.1472(3)Å
α=90° β=94.9636(11)° γ=90°
C16H28F12Mn2O18S4
C16H28F12Mn2O18S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2497-2509
a=13.6419(2)Å b=9.97668(13)Å c=13.8425(2)Å
α=90° β=105.4760(16)° γ=90°
C12H18F12MnN2O12S4
C12H18F12MnN2O12S4
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2497-2509
a=39.801(2)Å b=15.0805(11)Å c=8.9654(5)Å
α=90° β=90° γ=90°
C12H36MnO6S6,2(C2F6NO4S2)
C12H36MnO6S6,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2497-2509
a=8.0015(6)Å b=10.9806(9)Å c=12.9203(8)Å
α=109.047(7)° β=99.445(6)° γ=97.393(6)°
2(C2F6NO4S2),H12MnO6
2(C2F6NO4S2),H12MnO6
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2497-2509
a=10.4969(4)Å b=23.2549(14)Å c=10.2815(4)Å
α=90° β=90.464(4)° γ=90°
0.5(C4H8F12Mn2O16S4),C6H14O3
0.5(C4H8F12Mn2O16S4),C6H14O3
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2497-2509
a=9.6566(3)Å b=20.1455(9)Å c=10.0161(4)Å
α=90° β=90° γ=90°
C24H36MnN12,2(C2F6NO4S2)
C24H36MnN12,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2017) 46, 8 2497-2509
a=8.3943(3)Å b=11.1474(5)Å c=24.3863(9)Å
α=90° β=97.523(4)° γ=90°
C30H48CoN12,2(C2F6NO4S2)
C30H48CoN12,2(C2F6NO4S2)
Dalton Trans. (2017)
a=11.0532(5)Å b=11.1257(5)Å c=20.1637(10)Å
α=90° β=98.154(5)° γ=90°
C36H60CoN12,2(C2F6NO4S2)
C36H60CoN12,2(C2F6NO4S2)
Dalton Trans. (2017)
a=11.15538(16)Å b=12.3581(3)Å c=21.4046(3)Å
α=90° β=101.7361(15)° γ=90°
C42H72Co1N12,2(C1H3O3S1)
C42H72Co1N12,2(C1H3O3S1)
Dalton Trans. (2017)
a=13.4995(7)Å b=13.4995(7)Å c=25.8633(14)Å
α=90° β=90° γ=120°
1.5(C30H48CoN12),3(CH3O3S)
1.5(C30H48CoN12),3(CH3O3S)
Dalton Trans. (2017)
a=23.6765(7)Å b=12.9804(4)Å c=21.7673(7)Å
α=90° β=112.358(4)° γ=90°
2(C18H30Co0.5N6),2(CH3O3S)
2(C18H30Co0.5N6),2(CH3O3S)
Dalton Trans. (2017)
a=8.8446(3)Å b=15.7075(6)Å c=17.6599(7)Å
α=88.763(3)° β=80.229(3)° γ=85.243(3)°
C21H36Co0.5N6,C21H35Co0.5N6,2(C2F6NO4S2)
C21H36Co0.5N6,C21H35Co0.5N6,2(C2F6NO4S2)
Dalton Trans. (2017)
a=9.6957(3)Å b=17.4965(6)Å c=18.8465(6)Å
α=88.258(3)° β=89.339(3)° γ=80.363(3)°
Bis(N-butylimidazole)silver bistriflimide
C14H24AgN4,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=8.9816(7)Å b=16.8076(12)Å c=18.0174(18)Å
α=111.575(3)° β=90.026(6)° γ=97.337(4)°
(N-butylimidazole)(N-ethylimidazole)silver bistriflimide
C12H20AgN4,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=15.2285(9)Å b=8.9449(7)Å c=18.0327(11)Å
α=90.00° β=114.034(3)° γ=90.00°
Bis(N-methylimidazole)silver bistriflimide
C2F6NO4S2,C8H12AgN4
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=11.9627(5)Å b=9.0478(3)Å c=17.1295(8)Å
α=90.00° β=90.760(2)° γ=90.00°
(N-butylimidazole)(N-methylimidazole)silver bistriflimide
C11H18AgN4,C2F6NO4S2
Dalton transactions (Cambridge, England : 2003) (2012) 41, 23 6902-6905
a=14.7961(11)Å b=9.0675(6)Å c=17.9641(15)Å
α=90.00° β=109.152(9)° γ=90.00°
C54H38CuN4
C54H38CuN4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 39 14188-14199
a=13.7700(4)Å b=13.5622(4)Å c=21.6416(6)Å
α=90.00° β=94.943(2)° γ=90.00°
C30H22CuN4
C30H22CuN4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 39 14188-14199
a=17.0388(7)Å b=15.6229(7)Å c=19.7025(7)Å
α=90.00° β=115.496(2)° γ=90.00°
C54H38CuN4
C54H38CuN4
Dalton transactions (Cambridge, England : 2003) (2013) 42, 39 14188-14199
a=18.9299(5)Å b=10.5052(3)Å c=21.7918(6)Å
α=90.00° β=113.925(2)° γ=90.00°
Bis(pyridine-N-oxide)silver nitrate
C10H10AgN3O5
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=8.2360(4)Å b=8.7680(5)Å c=8.7895(4)Å
α=77.874(5)° β=80.894(4)° γ=72.726(5)°
C11H13AgN2O5S
C11H13AgN2O5S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=11.6002(2)Å b=6.90176(12)Å c=17.1007(4)Å
α=90.00° β=104.866(2)° γ=90.00°
C15H15AgN3O3,CF3O3S
C15H15AgN3O3,CF3O3S
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=25.9649(5)Å b=25.9649(5)Å c=11.8154(3)Å
α=90.00° β=90.00° γ=90.00°
C40H40Ag3N8O8,3(CF3O3S)
C40H40Ag3N8O8,3(CF3O3S)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=7.0275(3)Å b=25.8608(10)Å c=14.6674(4)Å
α=90.00° β=90.519(3)° γ=90.00°
Tris(pyridine-N-oxide) silver bistriflimide
C45H45Ag3N9O9,3(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 4 1589-1598
a=25.5554(4)Å b=25.5554(4)Å c=56.4189(11)Å
α=90.00° β=90.00° γ=120.00°
C42H30EuNO8,C13H8O2
C42H30EuNO8,C13H8O2
Chemical Communications (2005) 5
a=13.6463(2)Å b=13.8170(2)Å c=14.7689(2)Å
α=110.7920(10)° β=115.3580(10)° γ=98.4080(10)°
Bis(N-methylimidazole)silver nitrate
C8H12AgN4,NO3
Physical chemistry chemical physics : PCCP (2013) 15, 43 18934-18943
a=6.2877(2)Å b=7.7823(4)Å c=12.5635(5)Å
α=88.036(4)° β=89.839(3)° γ=76.687(4)°
Bis(N-butylimidazole)silver nitrate
C14H24AgN4,NO3
Physical chemistry chemical physics : PCCP (2013) 15, 43 18934-18943
a=16.4340(13)Å b=7.8736(7)Å c=13.8845(13)Å
α=90.00° β=106.748(9)° γ=90.00°
Bis(N-dodecylimidazole)silver nitrate dihydrate
C30H56AgN4,NO3,2(H2O)
Physical chemistry chemical physics : PCCP (2013) 15, 43 18934-18943
a=4.5579(4)Å b=8.2220(5)Å c=23.099(2)Å
α=89.274(7)° β=87.415(7)° γ=78.188(6)°
4(C12H18MnMo6N8O26),11(C16H36N),C14.62H30.23N,10(C2H3N),0.5(C2H6O)
4(C12H18MnMo6N8O26),11(C16H36N),C14.62H30.23N,10(C2H3N),0.5(C2H6O)
Dalton transactions (Cambridge, England : 2003) (2015) 44, 44 19059-19062
a=22.0899(3)Å b=29.6893(4)Å c=31.1610(5)Å
α=112.9562(15)° β=91.6469(13)° γ=102.4493(12)°
Hexakis(N-methylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C24H36N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=8.18271(10)Å b=20.1947(3)Å c=27.0549(3)Å
α=90.00° β=92.4412(10)° γ=90.00°
N-methylimidazole pentakis(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C29H46N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=11.0036(3)Å b=11.1127(3)Å c=20.1049(5)Å
α=90.00° β=98.316(2)° γ=90.00°
Hexakis(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C30H48N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=11.0834(5)Å b=11.1196(4)Å c=20.2237(7)Å
α=90.00° β=98.423(4)° γ=90.00°
Bis(N-methylimidazole) tetrakis(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C28H44N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=10.9682(4)Å b=11.1202(4)Å c=20.0576(6)Å
α=90.00° β=98.463(3)° γ=90.00°
C25H17F24NNdO9,0.39(O)
C25H17F24NNdO9,0.39(O)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 30 11566-11578
a=11.03826(19)Å b=18.5663(5)Å c=17.8663(3)Å
α=90.00° β=92.0479(17)° γ=90.00°
4.5(N-methylimidazole) 1.5(N-ethylimidazole) zinc(II) bis(trifluoromethylsulfony)limide
C25.5H39N12Zn,2(C2F6NO4S2)
Dalton transactions (Cambridge, England : 2003) (2014) 43, 32 12329-12341
a=8.3667(2)Å b=11.5721(3)Å c=24.0909(4)Å
α=90.00° β=95.811(2)° γ=90.00°
C9H11N2,C2F6NO4S2
C9H11N2,C2F6NO4S2
The journal of physical chemistry. B (2011) 115, 26 8424-8438
a=8.255(3)Å b=13.880(3)Å c=14.205(4)Å
α=90.00° β=92.159(18)° γ=90.00°
(5-Bromo-3-hydroxybenzofuran-2-yl)(4-fluorophenyl)methanone
C15H8BrFO3
Acta Crystallographica Section C (2020) 76, 9
a=3.8598(4)Å b=11.7229(10)Å c=27.679(2)Å
α=90° β=93.255(9)° γ=90°
(5-Bromo-3-hydroxybenzofuran-2-yl)(4-chlorophenyl)methanone
C15H8BrClO3
Acta Crystallographica Section C (2020) 76, 9
a=26.4034(10)Å b=3.98180(10)Å c=26.2773(10)Å
α=90° β=104.605(4)° γ=90°
(4-Bromophenyl)(3-hydroxy-5-iodobenzofuran-2-yl)methanone
C15H8BrIO3
Acta Crystallographica Section C (2020) 76, 9
a=26.4214(8)Å b=4.76309(13)Å c=46.6213(14)Å
α=90° β=106.034(3)° γ=90°
[η^2^-4-Allyl-2-methoxy-1-(propoxycarbonylmethoxy)benzene]-<i>trans</i>-dichlorido(quinoline-κ<i>N</i>)platinum(II)
C24H27Cl2NO4Pt
Acta Crystallographica Section C (2018) 74, 12
a=8.1252(3)Å b=11.7042(4)Å c=13.7340(5)Å
α=65.864(4)° β=84.716(3)° γ=88.191(3)°
[η^2^-4-Allyl-2-methoxy-1-(propoxycarbonylmethoxy)benzene]chlorido(quinolin-8-olato-κ^2^<i>N</i>,<i>O</i>)platinum(II)
C24H26ClNO5Pt
Acta Crystallographica Section C (2018) 74, 12
a=8.3447(2)Å b=11.9191(4)Å c=12.9315(5)Å
α=63.296(4)° β=84.618(3)° γ=76.484(3)°
[η^2^-4-Allyl-2-methoxy-1-(propoxycarbonylmethoxy)benzene]chlorido(quinolin-2-carboxylato-κ^2^<i>N</i>,<i>O</i>)platinum(II)
C25H26ClNO6Pt
Acta Crystallographica Section C (2018) 74, 12
a=15.6457(13)Å b=9.7291(4)Å c=16.6062(8)Å
α=90° β=111.150(8)° γ=90°
{η^2^-4-Allyl-2-methoxy-1-[(propan-2-yloxy)carbonylmethoxy]benzene}chlorido(quinolin-8-olato-κ^2^<i>N</i>,<i>O</i>)platinum(II)
C24H26ClNO5Pt
Acta Crystallographica Section C (2018) 74, 12
a=9.7858(3)Å b=11.0447(2)Å c=11.8117(3)Å
α=85.059(2)° β=73.685(3)° γ=71.139(2)°
Potassium [2-methoxy-4-(prop-2-en-1-yl)phenol]trichloridoplatinate
C10H12Cl3KO2Pt
Acta Crystallographica Section C (2017) 73, 11 1030-1037
a=12.0312(6)Å b=16.1528(8)Å c=8.1007(4)Å
α=90° β=107.295(6)° γ=90°
Chlorido(5,7-dichloroquinolin-8-olato-κ^2^<i>N</i>,<i>O</i>)[η^2^-2-methoxy4-(prop-2-en-1-yl)phenol]platinum(II)
C19H16Cl3NO3Pt
Acta Crystallographica Section C (2017) 73, 11 1030-1037
a=8.1313(3)Å b=11.2960(5)Å c=11.4294(7)Å
α=88.793(4)° β=76.567(4)° γ=70.219(4)°
2-[4-Acetyl-5-(4-fluorophenyl)-5-methyl-4,5-dihydro-1,3,4-oxadiazol-2-yl]-4-iodophenyl acetate
C19H16FIN2O4
Acta Crystallographica Section C (2018) 74, 7
a=9.1241(4)Å b=20.0980(9)Å c=10.7456(5)Å
α=90° β=110.224(2)° γ=90°
2-[4-Acetyl-5-(4-chlorophenyl)-5-methyl-4,5-dihydro-1,3,4-oxadiazol-2-yl]-4-iodophenyl acetate
C19H16ClIN2O4
Acta Crystallographica Section C (2018) 74, 7
a=11.703(2)Å b=22.037(4)Å c=7.4073(12)Å
α=90° β=92.888(8)° γ=90°
2-(4-Acetyl-5-methyl-5-phenyl-4,5-dihydro-1,3,4-oxadiazol-2-yl)-4-iodophenyl acetate
C19H17IN2O4
Acta Crystallographica Section C (2018) 74, 7
a=8.8370(10)Å b=20.0560(10)Å c=11.0150(10)Å
α=90° β=110.180(10)° γ=90°
(Acetonitrile-κ<i>N</i>)(η^2^-2-allyl-4-methoxy-5-{[(propan-2-yloxy)\ carbonyl]methoxy}phenyl-κ<i>C</i>^1^)chloridoplatinum(II) monohydrate
C17H22ClNO4Pt,H2O
Acta Crystallographica Section C (2016) 72, 10 758-764
a=8.3747(4)Å b=10.5732(5)Å c=11.0883(4)Å
α=76.670(4)° β=89.496(3)° γ=82.641(4)°
(η^2^-2-Allyl-4-methoxy-5-{[(propan-2-yloxy)carbonyl]methoxy}phenyl-κ<i>C</i>^1^)chlorido(dimethyl sulfoxide-κ<i>N</i>)platinum(II)
C16H23ClO5PtS
Acta Crystallographica Section C (2016) 72, 10 758-764
a=8.7920(3)Å b=12.1383(4)Å c=17.4745(6)Å
α=87.030(3)° β=82.074(3)° γ=87.651(3)°
Di-μ-chlorido-bis[(η^2^-2-allyl-4-methoxy-5-{[(propan-2-yloxy)carbonyl]methoxy}phenyl-κ<i>C</i>^1^)platinum(II)]
C30H38Cl2O8Pt2
Acta Crystallographica Section C (2016) 72, 10 758-764
a=13.5600(3)Å b=7.98332(19)Å c=15.8057(4)Å
α=90° β=104.815(3)° γ=90°
C13H15N2,Cl,2(H2O)
C13H15N2,Cl,2(H2O)
Acta Crystallographica Section B (2016) 72, 5 771-774
a=17.8252(7)Å b=7.2708(2)Å c=20.6396(7)Å
α=90° β=90° γ=90°
(η^2^-2-Allyl-4-methoxy-5-{[(propan-2-yloxy)carbonyl]methoxy}phenyl-κ<i>C</i>^1^)chlorido(pyridine-κ<i>N</i>)platinum(II)
C20H24ClNO4Pt
Acta Crystallographica Section E (2020) 76, 7 1012-1017
a=8.3146(3)Å b=8.6714(4)Å c=14.5827(6)Å
α=90.534(4)° β=104.376(4)° γ=101.135(3)°
(η^2^-2-Allyl-4-methoxy-5-{[(propan-2-yloxy)carbonyl]methoxy}phenyl-κ<i>C</i>^1^)chlorido(4-methylpyridine-κ<i>N</i>)platinum(II)
C21H26ClNO4Pt
Acta Crystallographica Section E (2020) 76, 7 1012-1017
a=8.36089(15)Å b=9.12717(16)Å c=14.5582(3)Å
α=94.9089(15)° β=102.2766(16)° γ=100.4541(15)°
(η^2^-2-Allyl-4-methoxy-5-{[(propan-2-yloxy)carbonyl]methoxy}phenyl-κ<i>C</i>^1^)chlorido(pyridine-4-carboxylic acid-κN)platinum(II)
C21H24ClNO6Pt
Acta Crystallographica Section E (2020) 76, 7 1012-1017
a=7.8746(2)Å b=9.7566(2)Å c=15.0004(4)Å
α=95.782(2)° β=102.874(2)° γ=93.843(2)°
Ethyl 2-[(4-oxo-3-phenyl-3,4-dihydroquinazolin-2-yl)sulfanyl]acetate
C18H16N2O3S
Acta Crystallographica Section E (2020) 76, 5 668-672
a=11.8865(6)Å b=5.1298(3)Å c=28.2942(14)Å
α=90° β=93.667(4)° γ=90°
Diethyl 2,6-dimethyl-4-(thiophen-3-yl)-1,4-dihydropyridine-3,5-dicarboxylate
C17H21NO4S
Acta Crystallographica Section E (2019) 75, 12 1861-1865
a=15.6801(8)Å b=7.4311(3)Å c=15.5968(8)Å
α=90° β=111.424(6)° γ=90°
4-[3-(4-Hydroxyphenyl)-4,5-dihydro-1<i>H</i>-pyrazol-5-yl]-2-methoxyphenol monohydrate
C16H16N2O3,H2O
Acta Crystallographica Section E (2019) 75, 11 1590-1594
a=12.1452(5)Å b=8.1784(3)Å c=31.2738(12)Å
α=90° β=90° γ=90°
(<i>E</i>)<i>-N</i>'-[1-(4-Aminophenyl)ethylidene]-2-hydroxy-5-iodobenzohydrazide methanol monosolvate
C15H14IN3O2,CH4O
Acta Crystallographica Section E (2018) 74, 7 910-914
a=12.9877(10)Å b=14.8982(10)Å c=8.5593(6)Å
α=90° β=91.806(2)° γ=90°
4-Phenyl-3-(thiophen-3-yl-methyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C13H11N3S2
Acta Crystallographica Section E (2018) 74, 6 812-815
a=8.8257(8)Å b=16.0776(16)Å c=9.7437(9)Å
α=90° β=116.383(3)° γ=90°
(2<i>E</i>)-1-(4-Hydroxy-1-methyl-2-oxo-1,2-dihydroquinolin-3-yl)-3-(4-hydroxy-3-methoxyphenyl)prop-2-en-1-one
C20H17NO5
Acta Crystallographica Section E (2015) 71, 4 424-426
a=8.3634(8)Å b=22.664(2)Å c=8.8079(9)Å
α=90.00° β=95.413(3)° γ=90.00°
Hexaaquanickel(II) bis{5-bromo-7-[(2-hydroxyethyl)amino]-1-methyl-6-oxidoquinoline-1-ium-3-sulfonate} monohydrate
NiH12O62,2(C12H12BrN2O5S),H2O
Acta Crystallographica Section E (2016) 72, 9 1242-1245
a=8.7315(4)Å b=27.4581(13)Å c=13.7943(6)Å
α=90° β=94.061(4)° γ=90°
(2-Aminopyridine-κ<i>N</i>)chlorido{5-ethoxycarbonylmethoxy-4-methoxy-1-[(2,3-η)-prop-2-en-1-yl]phenyl-κ<i>C</i>^1^}platinum(II)
C19H23ClN2O4Pt
Acta Crystallographica Section E (2017) 73, 4 573-578
a=15.1198(5)Å b=10.0855(2)Å c=14.1855(4)Å
α=90° β=117.329(4)° γ=90°
<i>trans</i>-(2-Aminopyridine-κ<i>N</i>)dichlorido{4-ethoxycarbonylmethoxy-3-methoxy-1-[(2,3-η)-prop-2-en-1-yl]benzene}platinum(II)
C19H24Cl2N2O4Pt
Acta Crystallographica Section E (2017) 73, 4 573-578
a=8.3187(3)Å b=11.4119(3)Å c=12.1012(4)Å
α=70.437(3)° β=73.688(3)° γ=87.038(2)°
<i>N</i>'-[1-(4-Hydroxyphenyl)benzylidene]-2-(thiophen-3-yl)acetohydrazide
C13H12N2O2S
Acta Crystallographica Section E (2019) 75, 8 1090-1095
a=13.0820(8)Å b=8.0287(4)Å c=24.0442(12)Å
α=90° β=90° γ=90°
1-(4-Hydroxyphenyl)-3-(thiophen-3-yl)prop-1-en-3-one
C13H10O2S
Acta Crystallographica Section E (2019) 75, 7 957-963
a=11.0808(5)Å b=9.0251(5)Å c=22.8157(10)Å
α=90° β=90° γ=90°
1-(4-Methoxyphenyl)-3-(thiophen-3-yl)prop-1-en-3-one
C14H12O2S
Acta Crystallographica Section E (2019) 75, 7 957-963
a=16.4118(13)Å b=5.8387(5)Å c=12.6456(9)Å
α=90° β=97.279(7)° γ=90°
1-(4-Bromophenyl)-3-(thiophen-3-yl)prop-1-en-3-one
C13H9BrOS
Acta Crystallographica Section E (2019) 75, 7 957-963
a=14.1245(7)Å b=14.2016(13)Å c=5.8809(4)Å
α=90° β=98.081(6)° γ=90°
1-(4-Ethoxyphenyl)-3-(thiophen-3-yl)prop-1-en-3-one
C15H14O2S
Acta Crystallographica Section E (2019) 75, 7 957-963
a=16.5120(8)Å b=7.7851(5)Å c=10.4913(5)Å
α=90° β=96.813(4)° γ=90°
<i>N</i>-{[(2-Hydroxyphenyl)methylidene]amino}morpholine-4-carbothioamide
C12H15N3O2S
Acta Crystallographica Section E (2019) 75, 9 1389-1393
a=11.7579(4)Å b=15.0584(5)Å c=7.1103(3)Å
α=90° β=90° γ=90°
<i>N</i>'-[1-(4-Methoxyphenyl)benzylidene]-2-(thiophen-3-yl)acetohydrazide
C14H14N2O2S
Acta Crystallographica Section E (2019) 75, 8 1090-1095
a=6.5185(2)Å b=9.7447(5)Å c=10.9291(6)Å
α=78.327(4)° β=83.070(4)° γ=87.013(4)°
<i>trans</i>-Dichlorido(4-chloroaniline-κ<i>N</i>){4-ethoxycarbonylmethoxy-3-methoxy-1-[(2,3-η)-prop-2-en-1-yl]benzene}platinum(II)
C20H24Cl3NO4Pt
Acta Crystallographica Section E (2016) 72, 7 912-917
a=9.9093(3)Å b=10.0102(3)Å c=11.1414(4)Å
α=97.302(3)° β=99.706(3)° γ=92.572(2)°
<i>trans</i>-Dichlorido(4-chloroaniline-κ<i>N</i>){3-methoxy-4-methoxycarbonylmethoxy-1-[(2,3-η)-prop-2-en-1-yl]benzene}platinum(II) 0.1-hydrate
C19H22Cl3NO4Pt,0.1(H2O)
Acta Crystallographica Section E (2016) 72, 7 912-917
a=13.8322(6)Å b=15.0753(4)Å c=21.0367(9)Å
α=90° β=106.683(5)° γ=90°
4-Amino-3-(thiophen-3-ylmethyl)-1<i>H</i>-1,2,4-triazole-5(4<i>H</i>)-thione
C7H8N4S2
Acta Crystallographica Section E (2017) 73, 9 1389-1392
a=7.6904(4)Å b=13.0429(7)Å c=9.0220(4)Å
α=90° β=90.081(2)° γ=90°
Dicalcium octaneodymium hexakis(orthosilicate) dioxide
Ca2.49Nd7.51O25.75Si6
Acta Crystallographica Section E (2016) 72, 2 209-211
a=9.5507(3)Å b=9.5507(3)Å c=7.0513(3)Å
α=90.00° β=90.00° γ=120.00°
<i>N</i>-(4-Oxo-2-sulfanylidene-1,3-thiazolidin-3-yl)-2-(thiophen-3-yl)acetamide
C9H8N2O2S3
Acta Crystallographica Section E (2017) 73, 6 901-904
a=9.6205(3)Å b=10.8252(3)Å c=11.5073(3)Å
α=97.836(2)° β=102.720(2)° γ=95.047(2)°
4-(Pyridin-3-ylethynyl)-2,2'-bipyridine
C17H11N3
Acta Crystallographica Section E (2017) 73, 4 610-615
a=3.7436(3)Å b=34.146(3)Å c=10.7528(9)Å
α=90° β=94.799(8)° γ=90°
4-(Indol-4-yl)-2,2'-bipyridine
C18H13N3
Acta Crystallographica Section E (2017) 73, 4 610-615
a=9.6951(6)Å b=12.0142(7)Å c=12.0376(9)Å
α=90.00° β=109.552(8)° γ=90.00°
4-(4-Methylphenylethynyl)-2,2'-bipyridine
C19H14N2
Acta Crystallographica Section E (2017) 73, 4 610-615
a=9.8697(7)Å b=12.6040(7)Å c=22.8414(13)Å
α=90.00° β=97.890(6)° γ=90.00°
5-Benzyl-8-bromo-2-methyl[1,3]oxazolo[4,5-<i>c</i>]-1,8-naphthyridin-4(5<i>H</i>)-one
C17H12BrN3O2
Acta Crystallographica Section E (2017) 73, 5 687-690
a=6.7150(13)Å b=13.504(3)Å c=16.757(3)Å
α=90° β=90° γ=90°
Chlorido{4,5-dimethoxy-2-[(2,3-η)-2-prop-2-en-1-yl]phenyl-κ<i>C</i>^1^}(piperidine-κ<i>N</i>)platinum(II) ethanol monosolvate
C16H24ClNO2Pt,C2H6O
Acta Crystallographica Section E (2014) 70, 11 435-437
a=8.5280(2)Å b=8.7520(2)Å c=13.3309(3)Å
α=97.9050(10)° β=97.6840(10)° γ=99.8800(10)°
<i>trans</i>-Dichlorido(4-nitroaniline-κ<i>N</i>^1^)(piperidine-\ κ<i>N</i>)platinum(II)
C11H17Cl2N3O2Pt
Acta Crystallographica Section E (2015) 71, 6 644-646
a=15.8763(11)Å b=18.5394(11)Å c=10.8707(6)Å
α=90.00° β=103.119(7)° γ=90.00°
Hexaaquanickel(II) bis(5,6-dihydroxy-3-sulfoquinolin-7-yloxyacetic acid) dihydrate
H12NiO6,C22H16N2O16S2,2H2O
Acta Crystallographica Section E (2015) 71, 9 1105-1108
a=8.1632(5)Å b=8.2829(6)Å c=11.8492(8)Å
α=102.316(6)° β=102.250(6)° γ=93.003(6)°
3,6-Dibromo-5-(4-<i>tert</i>-butylstyryl)2-(naphthalen-1-yl)thieno[3,2-<i>b</i>]thiophene
C28H22Br2S2
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 895-899
a=8.3316(3)Å b=16.1749(6)Å c=18.1333(6)Å
α=90.00° β=96.677(3)° γ=90.00°
3,6-Dibromo-5-(4-methylstyryl)-2-(naphthalen-1-yl)thieno[3,2-<i>b</i>]thiophene
C25H16Br2S2
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 895-899
a=4.1522(3)Å b=13.2861(14)Å c=19.6117(18)Å
α=106.464(9)° β=94.945(7)° γ=93.016(7)°
3,6-Dibromo-2-(4-<i>tert</i>-butylphenyl)-5-(4-methylstyryl)thieno[3,2-<i>b</i>]thiophene
C25H22Br2S2
Acta crystallographica. Section C, Structural chemistry (2014) 70, Pt 9 895-899
a=9.5401(12)Å b=10.1575(17)Å c=12.1711(16)Å
α=106.933(13)° β=98.599(11)° γ=92.192(13)°
3-(Benzothiazol-2-yl)thiophene
C11H7NS2
Acta crystallographica. Section E, Crystallographic communications (2017) 73, Pt 11 1647-1651
a=6.1368(4)Å b=13.9799(9)Å c=11.4609(7)Å
α=90° β=100.193(2)° γ=90°
5,8-di(4-methoxy-2,3,6-trimethylbenzenesulphonyl)-1,4-dioxa-5,8-diazaocane
C24H34N2O8S2
Acta Crystallographica Section C (1997) 53, 8 1131-1133
a=9.0790(10)Å b=10.188(2)Å c=14.920(2)Å
α=74.490(10)° β=80.000(10)° γ=83.130(10)°
6-(3,5-Di-O-acetyl-β-D-2-deoxyribofuranosyl)-3,4-dihydro-8-H-pyrimido[4,5-c][1,2]oxazin-7-one
C15H19N3O7
Acta Crystallographica Section C (1995) 51, 7 1347-1350
a=14.662(3)Å b=5.4190(10)Å c=21.475(4)Å
α=90.00° β=101.66(3)° γ=90.00°